CGAS and metabolic dysfunction-associated steatotic liver disease: In addition to playing a role in nonalcoholic fatty liver disease (NAFLD) development, activation of the cGAS‒STING signaling pathway has also been shown to contribute to liver injury in alcohol-related liver disease (ALD) (Petrasek et al., 2013; Luther et al., 2020).